HELIOS Kliniken

Hospital


Location: diverse, Germany (DE) DE

ISNI: 0000000105499953

ROR: https://ror.org/04fjkxc67

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2019 (2019) Ditsch N, Untch M, Thill M, Müller V, Janni W, Albert US, Bauerfeind I, et al. Journal article Qualität statt Quantität verbessert die Weiterbildung (2019) König J, Aeishen S, Cebulla A, Bellut L, Fassbach M, Westphal J, Struck JP Journal article, Review article Mutational diversity and therapy response in breast cancer: A sequencing analysis in the neoadjuvant geparsepto trial (2019) Loibl S, Treue D, Budczies J, Weber K, Stenzinger A, Schmitt WD, Weichert W, et al. Journal article Fatal events during clinical trials: an evaluation of deaths during breast cancer studies (2019) Furlanetto J, von Minckwitz G, Lederer B, Möbus V, Schneeweiss A, Huober J, Fasching P, et al. Journal article Pruritus bei systemischen Erkrankungen (2019) Kremer A, Mettang T Journal article, Review article Primary Therapy of Early Breast Cancer: Evidence, Controversies, Consensus (2019) Untch M, Thomssen C, Bauerfeind I, Braun M, Brucker SY, Felberbaum R, Hagemann F, et al. Journal article Acyltransferase skinny hedgehog regulates TGFβ-dependent fibroblast activation in SSc (2019) Liang R, Kagwiria R, Zehender A, Dees C, Bergmann C, Krasowska D, Michalska-Jakubus M, et al. Journal article Concerning Dediu M, Zielinski A: A Proposal to Redefine Pathologic Complete Remission as Endpoint following Neoadjuvant Chemotherapy in Early Breast Cancer. Breast Care 2019; Doi 10.1159/000500620 (2019) Untch M, Loibl S, Fasching P Journal article, Letter Intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for neoadjuvant treatment of high-risk early breast cancer (GeparOcto—GBG 84): A randomised phase III trial (2019) Schneeweiss A, Moebus V, Tesch H, Hanusch C, Denkert C, Luebbe K, Huober J, et al. Journal article Predictors for the Development of Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD) - Data from the German SSc-Network (2019) Kreuter M, Bonella F, Blank N, Siegert E, Henes J, Worm M, Sunderkoetter C, et al. Conference contribution